Dendritic cells generated from the blood of patients with multiple myeloma are phenotypically and functionally identical to those similarly produced from healthy donors

British Journal of Haematology

Volumn 98, Issue 4, 1997, Pages 973-982

  Pfeiffer, S ^a   Gooding, R P ^a   Apperley, J F ^a   Goldschmidt, H ^b   Samson, D ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Dendritic cells; Immunotherapy; Multiple myeloma

Indexed keywords

B7 ANTIGEN; CD1 ANTIGEN; CD86 ANTIGEN; HLA DR ANTIGEN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MALE; MIXED LYMPHOCYTE REACTION; MULTIPLE MYELOMA; PRIORITY JOURNAL;

EID: 0030843411     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.3123128.x     Document Type: Article

References (40)

1. Alexandroff, A.B. & Skibinsky, G. (1996) Nonclassical subpopulations of lymphocytes, dendritic cells and stromal microenvironment. Immunology News, 3, 186-189.
2. Attal, M., Harousseau, J.L., Stoppa, A.M., Sotto, J.J., Fuzibet, J.G., Rossi, J.F., Casassus, P., Maisonneuve, H., Facon, T., Ifrah, N., Payen, C. & Bataille, R. (1996) A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. New England Journal of Medicine, 335, 91-97.
3. + hematopoietic progenitor cells of the bone marrow and peripheral blood. Cancer Research, 55, 1099-1104.
4. Broder, S., Humphrey, R., Durm, M., Blackman, M., Meade, B., Goldman, C., Strober, W. & Waldmann, T. (1975) Impaired synthesis of polyclonal (non-paraprotein) immunoglobulins by circulating lymphocytes from patients with multiple myeloma. New England Journal of Medicine, 293, 887-892.
5. Cohen, P.J., Cohen, P.A., Rosenberg, S.A., Katz, S.I. & Mule, J.J. (1994) Murine epidermal Langerhans cells and splenic dendritic cells present tumour associated antigens to primed T-cells. European Journal of Immunology, 24, 315-519.
6. Durie, B.G.M. & Salmon, S.E. (1975) A clinical staging system for multiple myeloma: correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival. Cancer, 36, 842-854.
7. Egner, W. & Hart, D.N. (1995) The phenotype of freshly isolated and cultured human bone marrow allostimulatory cells: possible heterogeneity in bone marrow dendritic cell populations. Immunology, 85, 611-620.
8. Egner, W., McKenzie, J.L., Smith, S.M., Beard, M.E.J. & Hart, D.N.J. (1993) Identification of potent mixed leukocyte reaction-stimulatory cells in human bone marrow. Journal of Immunology, 150, 3043-3053.
9. Flamand, V., Sornasse, T., Thielemans, K., Demanet, C., Bakkus, M., Bazin, H., Thielemans, F., Urbain, J. & Moser, F. (1994) Murine dendritic cells pulsed in vitro with tumour antigen induce tumour resistance in vivo. European Journal of Immunology, 24, 605-610.
10. Gahrton, G., Ura, S., Ljungman, P., Belanger, C., Brandt, L., Cavo, M., Thierry, F., Granena, A., Gore, M., Gratwohl, C., Löwenberg, B., Nikoskelainen, J., Reiffers, J.J., Samson, D., Verdonck, L. & Volin, L. (1991) Allogeneic bone marrow transplant in multiple myeloma. New England Journal of Medicine, 325, 1267-1273.
11. Gimmi, C.D., Freeman, G.J., Gribben, J.G., Grey, G. & Nadler, L.M. (1993) Human T cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proceedings of the National Academy of Sciences of the United States of America, 90, 6586-6590.
12. Gimmi, C.D., Freeman, G.J., Gribben, J.G., Sugita, K., Freedman, A.S., Morimoto, C. & Nadler, L.M. (1991) B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2. Proceedings of the National Academy of Sciences of the united States of America, 88, 6575-6579.
13. Holm, G., Bergenbrant, S., Levfert, A.K., Yi, Q., Ostterborg, A. & Melstedt, H. (1992) Anti-idiotypic immunity as a potential regulator in myeloma and related diseases. Annals of the New York Academy of Science, 636, 178-183.
14. Hoover, R.G. & Kornbluth, J. (1992) Immunoregulation of murine and human myeloma. Hematology/Oncology Clinics of North America, 6, 407-415.
15. Hsu, F.J., Benike, C., Fagnoni, F., Liles, T.M., Czerwinski, D., Taidi, B., Engleman, E.G. & Levy, R. (1996) Vaccination of patients with B-cell lymphoma using autologous antigen pulsed dendritic cells. Nature Medicine, 2, 52, 274-281.
16. Huang, Y.W. & Vitteta, E.S. (1995) Immunotherapy of multiple myeloma. Stem Cells, 13, 123-134.
17. Kayo, I., Metlay, J.P., Crowleyand, M.T. & Steinman, R.M. (1990) Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T-cells in situ. Journal of Experimental Medicine, 172, 631-640.
18. + T lymphocytes to peptide antigens in vivo. Journal of Immunobiology, 151, 6742-6750.
19. Ludwig, H. (1986) The clinical picture of multiple myeloma. Onkologie, 9, 202-206.
20. + T cells in tumour cell resistance against major histocompatiblity complex II molecule negative plasmacytoma cells. Cellular Immunology, 148, 177-183.
21. Mann, H.B. & Whitney, D.R. (1945) On a test of whether one of two random variables is stochastically larger than the other. Annals of Mathematical Statistics, 18, 50-60.
22. Massaia, M., Borrione, P., Attisano, C., Barral, P., Beggiato, E., Montacchini, L., Bianchi, A., Boccadoro, M. & Pileri, A. (1995) Dysregulated Fas and Bcl 2 expression leading to enhanced apoptosis in T cells of multiple myeloma patients. Blood, 85, 1787-1789.
23. + T cells in patients with multiple myeloma and paraproteinemia. Blood, 87, 3297-3306.
24. Omedé, P., Boccadoro, M., Fusaro, A., Gallone, G. & Pileri, A. (1993) Multiple myeloma: early plasma cell phenotype identifies patients with aggressive biological and clinical characteristics. British Journal of Haematology, 85, 504-513.
25. Osterberg, A., Yi, Q., Bergenbrant, S., Holm, G., Levfert, A.K. & Mellstedt, H. (1995) Idiotype-specific T cells in multiple myeloma stage I: an evolution by four different functional tests. British Journal of Haematology, 89, 110-116.
26. Paglieroni, T. & MacKenzie, M.R. (1977) Studies on the pathogenesis of an immune defect in multiple myeloma. Journal of Clinical Investigation, 59, 1120-1133.
27. Peters, H.H., Gieseler, R., Thiele, B. & Steinbach, F. (1996) Dendritic cells: from ontogenetic orphans to myelomonocytic descendants. Immunology Today, 17, 273-278.
28. Porgador, A., Snyder, D. & Gilboa, E. (1996) Induction of antitumor immunity using bone marrow-generated dendritic cells. Journal of Immunology, 156, 2918-2926.
29. Preudhome, J.L., Klein, M., LaBaume, S. & Sellgman, M. (1977) Idiotype-bearing and antigen-binding receptors produced by blood T lymphocytes in a case of human myeloma. European Journal of Immunology, 7, 840-844.
30. + progenitors in human bone marrow. Journal of Immunology, 149, 2681-2688.
31. Sallusto F. & Lanzavechia, A. (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by GM-CSF plus IL4 and downregulated by TNFα. Journal of Experimental Medicine, 179, 1109-1118.
32. Santilago-Schwarz, F., Belilos, E., Diamond, B. & Carsons, S.E. (1992) TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages. Journal of Leukocyte Biology, 52, 274-281.
33. Santilago-Schwarz, E., Coppock, D.L., Hindenburg, A.A. & Kern, J. (1994) Identification of a malignant counterpart of the monocyte-dendritic cell progenitor in an acute myeloid leukemia. Blood, 34, 3054-3062.
34. + blood progenitors for anticancer therapy. Experimental Haematology, 23, 1463-1471.
35. Szabolcs, P., Avigan, D., Gezelter, S., Ciocon, D.H., Moore, M.A.S., Steinman, R.M. & Young, J.W. (1996) Dendritic cells and macrophages can mature independently from a human bone marrow-derived, post-colony-forming unit intermediate. Blood, 87, 4520-4550.
36. + bone marrow precursors cultured with c-kit ligand. GM-CSF, and TNF-α. Journal of Immunology, 154, 5851-5861.
37. Udagawa, N., Takahashi, N., Akatsu, T., Tanaka, H., Sasaki, T., Nishibara, T., Koga, T., Martin, T.J. & Suda, T. (1990) Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow derived stromal cells. Proceedings of the National Academy of Sciences of the United States of America, 87, 7260-7264.
38. Yi, Q., Berebrant, S., Osterborg, A., Osbey, E., Ostman, R., Brorkholm, M., Holm, G. & Lefvert, A.K. (1993) T cell idiotypes on monoclonal immunoglobulins in patients with monoclonal gammopathies. Scandinavian Journal of Immunology, 58, 529-534.
39. Yi, Q., Holm, G. & Lefvert, A.K. (1996) Idiotype-induced T-cell stimulation requires antigen presentation in associate with HLA-DR molecules. Clinical and Experimental Immunology, 104, 359-365.
40. Yi, Q., Osterborg, A., Bergenbrant, S., Mellstedt, H., Holm, G. & Lefvert, A.A. (1995) Idiotype-reactive T-cell subsets and tumor load in monoclonal gammopathies. Blood, 86, 3043-3049.